Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brain
- 1 January 1989
- Vol. 3 (1), 96-97
- https://doi.org/10.1002/syn.890030113
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseasesNeuropsychopharmacology, 1987
- No D2 Receptor Increase in PET Study of SchizophreniaArchives of General Psychiatry, 1987
- Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive SchizophrenicsScience, 1986
- Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brainBiochemical Pharmacology, 1985
- Invivo receptor binding: Attempts to improve specific/ non-specific ratiosLife Sciences, 1979